Navigation Links
Novartis signs on to support Malaria No More's Power of One campaign to stride towards a future without malaria
Date:4/25/2013

BASEL, Switzerland, April 25, 2013 /PRNewswire/ -- Novartis and Malaria No More, a leading global charity determined to end malaria deaths, announced today that they are joining forces on the Power of One campaign to help close the treatment gap and accelerate progress in the fight against malaria. Over the next three years, Novartis will support the campaign financially and also donate up to three million full courses of its pediatric antimalarial drug to match the treatments donated by the public, doubling the impact of these donations.

"We believe that this innovative campaign will help speed malaria elimination," said Joseph Jimenez , Novartis Chief Executive Officer. "Novartis has been striving towards this goal for more than a decade, and we just reached the milestone of providing 600 million treatments without profit to patients in malaria-endemic countries. No one should die from malaria today."

Malaria is a preventable and treatable disease, yet a child dies from malaria every minute. This is against a backdrop of global funding gaps and concern that the gains made to defeat the disease could be reversed. The Power of One campaign aims to address this need by closing the global treatment gap between now and the end of 2015 through direct donations and existing government commitments.

"The Power of One campaign challenges the global public to help close the global treatment gap for malaria; Every dollar raised will buy and deliver a full course of life-saving child treatment," said Martin Edlund , CEO of Malaria No More. "We are delighted to be partnering with forward-thinking companies like Novartis to help end deaths from this disease—one dollar and one child at a time."

Novartis has joined the Power of One campaign with some of the world's most innovative companies, including Alere who will be providing malaria rapid diagnostic
'/>"/>

SOURCE Novartis
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Novartis Reports Omalizumab Significantly Improved Chronic Idiopathic Urticaria Symptoms in Patients Who Failed Standard Therapy
2. Novartis Pharma Logistics, Inc. voluntarily recalling in Jamaica select lots of certain over-the-counter products due to bottle closure defect
3. Novartis Pharma Logistics, Inc. voluntarily recalling in Trinidad & Tobago select lots of certain over-the-counter products due to bottle closure defect
4. Novartis Pharma Logistics, Inc. voluntarily recalling in Curacao select lots of certain over-the-counter products due to bottle closure defect
5. Novartis Pharma Logistics, Inc. voluntarily recalling in Aruba select lots of certain over-the-counter products due to bottle closure defect
6. Novartis Pharma Logistics, Inc. voluntarily recalling in Barbados select lots of certain over-the-counter products due to bottle closure defect
7. Continued Uptake of Novartis/Incytes Jakafi Will Be the Greatest Driver of Growth in the Myelofibrosis Therapy Market
8. Novartis highlights key data in patients with hematologic diseases and breast cancer with more than 140 abstracts at ASH and SABCS
9. Thesan Pharmaceuticals offentliggør første runde af venturefinansieringen ledt af Novo Ventures og Novartis Venture Funds i fællesskab
10. Thesan Pharmaceuticals annuncia un finanziamento di serie A co-gestito da Novo Ventures e Novartis Venture Funds
11. Thesan Pharmaceuticals gibt Serie-A-Finanzierung unter gemeinsamer Führung von Novo Ventures und Novartis Venture Funds bekannt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 10, 2014  Decision Resources Group finds that ... (ID) specialists are willing to prescribe Durata,s Dalvance ... use as OPAT, approximately two-thirds of the respondents ... their hospital inpatients. However, our findings indicate that ... initiated on OPAT following hospital discharge, and most ...
(Date:7/10/2014)... , July 10, 2014 Decision Resources ... awareness of the U.S. Food and Drug Administration,s (FDA) ... phosphate binder Velphoro, which was approved by the FDA ... chronic kidney disease (CKD) patients on dialysis. ... TreatmentTrends: Nephrology (US) Q2 2014 : ...
(Date:1/15/2014)... , Jan. 15, 2014 Most osteoporosis patients ... to a recent online survey* sponsored by Mission Pharmacal ... the National Osteoporosis Foundation online support community, revealed that ... medication that comes in a form other than a ...
Breaking Medicine Technology:Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3
... Roche NimbleGen (SIX: RO, ROG; Pink Sheets: RHHBY ... genomic services provider Ambry Genetics has officially become a ... EZ Exome workflow. They will provide target-enrichment services ... sequencing services for genetic research. Ambry Genetics has passed ...
... Luminex Corporation (Nasdaq: LMNX ) today announced ... Conference to be held September 20 - 22, 2010, ...   http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) (Logo:   http://www.newscom.com/cgi-bin/prnh/20100104/LUMINEXLOGO ) ... president and chief executive officer, will begin at 8:00 ...
Cached Medicine Technology:Ambry Genetics Becomes First Certified Service Provider in US for NimbleGen SeqCap EZ Exome 2Ambry Genetics Becomes First Certified Service Provider in US for NimbleGen SeqCap EZ Exome 3Luminex Corporation to Present at UBS Global Life Sciences Conference 2
(Date:7/13/2014)... (PRWEB) July 14, 2014 MED-Ed Facilities ... at our next conference, April 7+8 in Boston at ... attended at the recent event. Presentations by individuals or ... , To review the types of sessions that were ... Submit your proposal today! , Conference Director, ...
(Date:7/13/2014)... 14, 2014 MillionaireCasket.com is a professional supplier ... excellent wood caskets are selling well in the global market. ... cherry caskets and launched a special offer for all ... prices, all the company’s cherry caskets are made with superb ... must for people to show respect to the departed saint. ...
(Date:7/13/2014)... New York (PRWEB) July 13, 2014 ... Growth, Trends and Forecast 2013 - 2019 , Intraocular ... patients suffering from myopia or cataracts. The lenses are ... After the cataract surgery intraocular lens replaces the focusing ... switches with original crystalline lens to deliver the light ...
(Date:7/13/2014)... 13, 2014 Victorian Hotel has recently ... the rental of bikes for its "Cycle the City" ... Hotel to tour the area using a rental bicycle, ... enthusiasts love to call Vancouver home, as it is ... travel and picturesque journeys through the countryside. Vancouver hotel ...
(Date:7/13/2014)... July 13, 2014 Fuel additives are ... gasoline, diesel, jet fuel, kerosene, and so on, in ... responsible for reducing the corrosion effects caused by fuels ... added to any fuel, provide economies of scale in ... escalate the overall cost of the fuel products. , ...
Breaking Medicine News(10 mins):Health News:MED-Ed Facilities Conference Call for Speakers Open 2Health News:Brand New Cherry Caskets Unveiled By China Casket Supplier MillionaireCasket.com 2Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 4Health News:Victorian Hotel Creates Excitement by Adding "Cycle the City" Bike Rentals for Its Vancouver Hotel Rooms 2Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 2Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 3Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 4
... , , , ... Michael Jackson,s death, reports of anxiety, depression, insomnia and fatigue have ... his reliance on prescription drugs. But Beverly Hills anti-aging consultants Karen ... Jackson could have been suffering from male menopause for years. You ...
... NANJING, China, Aug. 5 /PRNewswire-Asia/ -- Simcere Pharmaceutical ... supplier of branded generic and,innovative anti-cancer pharmaceuticals in China, ... quarter results on Monday, August 17, 2009,after the market ... Ren, and chief financial officer, Frank Zhigang Zhao, will,host ...
... ATHLETES SARAH WILL AND CHRIS WADDELL TO RIDE ON SEPT. ... of the greatest Paralympic athletes in the world have signed on to ... and Sarah Will both plan to ride in the event, raising money ... , , Waddell and Will join over a dozen ...
... , , SAN FRANCISCO, Aug. ... depression, according to a study just published in the Journal ... to higher risk for poor health outcomes and complications from ... of an ongoing study of healthy adults aged 65 and ...
... ... ... -- United Benefit Advisors (UBA), in partnership with the National Association of Health Underwriters (NAHU), ... regarding what,s happening now in the national health care reform debate., , , , ,Janet ...
... , ARLINGTON, Va., Aug. 5 ... service, and KnujOn.com , an Internet compliance ... (online advertisements) for Internet pharmacies displayed on bing.com. The report ... by the authors were fake or illegal Internet pharmacies. , ...
Cached Medicine News:Health News:SimplyAgeless Believes Michael Jackson Could Have Been Going Through 'Male Menopause' 2Health News:Simcere Pharmaceutical Group to Announce 2009 Second Quarter Earnings on Monday, August 17, 2009 2Health News:Celebrity Paralympians Sign on to Kelly Brush Century Ride 2Health News:Celebrity Paralympians Sign on to Kelly Brush Century Ride 3Health News:Brain Fitness Reduces Risk of Onset of Depressive Symptoms 2Health News:UBA offers Free Webinar: NAHU Executive VP and CEO to Discuss Health Reform Bills 2Health News:UBA offers Free Webinar: NAHU Executive VP and CEO to Discuss Health Reform Bills 3Health News:Report: Microsoft Sponsoring Ads for Rogue Internet Pharmacies 2
The Nevyas Drape Support is the simple and inexpensive way to establish a zone of comfort for your patients during ophthalmic surgery which requires draping over the nose and mouth. Packaged in sets ...
... important standard in busy operating rooms. The unique ... and supports arms and wrists during ophthalmic surgery. ... fluids are collected. The bar also flips up ... transfer on and off the table. The metal ...
... system provides patients with the ability ... to reading. The telescope has ... viewing. The double lens caps ... 4x magnifications. Each flip-up reading ...
The TV-Mag is a 1.9x focusing telescope, used mainly for watching television. It has a large objective lens giving excellent light transmission and a wide field of view....
Medicine Products: